Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biocytogen Sells Option for ADC to Barcelona’s Ona Therapeutics

publication date: Dec 19, 2023

Beijing Biocytogen Pharma entered an agreement allowing Barcelona’s Ona Therapeutics to evaluate Biocytogen’s proprietary RenMice®-derived fully human antibodies against a specific tumor target. Ona will have an option to acquire an exclusive license to the antibodies for development, manufacturing and commercialization of an antibody-drug conjugate (ADC). Biocytogen will receive an upfront payment for the option, and it will be eligible to receive an option-exercise fee, milestone payments and royalties. Based on its gene editing technology, Biocytogen uses its genetically engineered proprietary platforms to discover novel drug candidates. More details...

Stock Symbol: (HK: 02315)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital